Evidence map›Paper›PMID 39896980›Full record

ArticleMaterials today. Bio2025

Corrigendum to 'Enhanced sclerotherapy for vascular malformations: A dual-mechanism approach using in-situ forming PATDs gel' [Mater. Today Bio 29 (2024) 101376].

Jizhuang Ma, Wenhan Li, Yu Ding, Yongfeng Chen, Xiaoyu Huang, Tong Yu, Di Song, Haoran Niu, Bao Li, Huichao Xie and 5 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Jizhuang MaSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang, 110016, China.
Wenhan LiUltrasound Department, Shengjing Hospital, China Medical University, Shenyang, China.
Yu DingSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang, 110016, China.
Yongfeng ChenSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang, 110016, China.
Xiaoyu HuangSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang, 110016, China.
Tong YuSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang, 110016, China.
Di SongSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang, 110016, China.
Haoran NiuSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang, 110016, China.
Bao LiSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang, 110016, China.
Huichao XieCollege of Pharmacy, Shenzhen Technology University, Shenzhen, 518118, China.
Keda ZhangCollege of Pharmacy, Shenzhen Technology University, Shenzhen, 518118, China.
Tianzhi YangDepartment of Basic Pharmaceutical Sciences, School of Pharmacy, Husson University, Bangor, ME, USA.
Xiaoyun ZhaoSchool of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang, 110016, China.
Xinggang YangSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang, 110016, China.
Pingtian DingCollege of Pharmacy, Shenzhen Technology University, Shenzhen, 518118, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.1016/j.mtbio.2024.101376.].

Identifiers

PMID39896980
PMCPMC11785548

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.